Keywords: astrazeneca, licenses, cyclacel, tech, 12m, signed, agreement

AstraZeneca licenses Cyclacel tech for $12M

Article | 18 April 2001

Print This

AstraZeneca has signed an agreement with Cyclacel under which it willpay the latter $12 million for the rights to develop its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in